Thyrocare Technologies Ltd
BSE: 539871
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 210.67+15.4% | 182.48-9.8% | 202.23+13.0% | 178.89+2.9% | 173.87+14.0% | 152.55-6.4% | 163.05 |
| Other Income | 3.72+8.5% | 3.43+50.4% | 2.28-42.4% | 3.96-12.8% | 4.54+29.3% | 3.51+65.5% | 2.12 |
| Total Income | 214.39+15.3% | 185.91-9.1% | 204.51+11.8% | 182.85+2.5% | 178.41+14.3% | 156.06-5.5% | 165.17 |
| EXPENSES | |||||||
| Expenditure | 152.41+6.3% | 143.32-0.2% | 143.62+8.9% | 131.94+1.0% | 130.61+1.9% | 128.12+2.6% | 124.83 |
| Tax | 18.40+75.7% | 10.47-41.4% | 17.86+20.2% | 14.86-42.5% | 25.85+192.4% | 8.84-17.8% | 10.75 |
| PROFIT | |||||||
| PBT | 61.98+69.3% | 36.62-39.9% | 60.89+19.6% | 50.91+6.5% | 47.80+71.1% | 27.94-30.7% | 40.34 |
| Net Profit | 43.58+66.7% | 26.15-39.2% | 43.03+19.4% | 36.05+64.2% | 21.95+14.9% | 19.10-35.4% | 29.59 |
| KEY METRICS | |||||||
| OPM % | 34.48%+5.82pp | 28.66%-5.42pp | 34.08%+2.49pp | 31.59%-0.41pp | 32.00%+26.36pp | 5.64%-11.31pp | 16.95% |
| NPM % | 20.33%+6.26pp | 14.07%-6.97pp | 21.04%+1.32pp | 19.72%+7.42pp | 12.30%+0.06pp | 12.24%-5.67pp | 17.91% |
| EPS | 2.75+67.7% | 1.64-79.8% | 8.12+19.4% | 6.80+66.7% | 4.08+15.6% | 3.53-36.9% | 5.59 |
Corporate Events
Board MeetingTHYROCARE
202630Jun
Board Meeting
The 26th Annual General Meeting of the Members of Thyrocare …
BSE Filing ↗ Board MeetingTHYROCARE
20267May
Board Meeting
Board of Directors meeting to consider and recommend a Final…
BSE Filing ↗ Board MeetingTHYROCARE
202414May
Board Meeting
Consider and approve audited standalone and consolidated fin…
BSE Filing ↗ Board MeetingTHYROCARE
20241Feb
Board Meeting
Approval of Unaudited Financial Results for the Quarter and …
BSE Filing ↗ Board MeetingTHYROCARE
202331Oct
Board Meeting
Consider and approve unaudited standalone and consolidated f…
BSE Filing ↗